Virological Control during the First 6–18 Months after Initiating Highly Active Antiretroviral Therapy as a Predictor for Outcome in HIV-Infected Patients: A Danish, Population-Based, 6-Year Follow-Up Study-Reference-Cited by-同舟云学术

Virological Control during the First 6–18 Months after Initiating Highly Active Antiretroviral Therapy as a Predictor for Outcome in HIV-Infected Patients: A Danish, Population-Based, 6-Year Follow-Up Study

Published:2006-01-01 Issue:1 Volume:42 Page:136-144
ISSN:1537-6591
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Lohse Nicolai,Kronborg Gitte,Gerstoft Jan,Larsen Carsten Schade,Pedersen Gitte,Pedersen Court,Sorensen Henrik Toft,Obel Niels

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/42/1/136/17850246/42-1-136.pdf

Reference33 articles.

1. AIDS across Europe, 1994–98: the EuroSIDA Study;Mocroft;Lancet,2000

2. Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA Study Group;Mocroft;AIDS,1999

3. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies;Egger;Lancet,2002

4. Durability and predictors of success of highly active antiretroviral therapy for ambulatory HIV-infected patients;Palella;AIDS,2002

5. Low Mortality in HIV-infected patients starting HAART in advance of immunological deterioration: a comparison with the general population;Jensen-Fangel;AIDS,2004

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Temporal dynamics and drivers of durable HIV viral load suppression and persistent high‐ and low‐level viraemia during Universal Test and Treat scale‐up in Uganda: a population‐based study;Journal of the International AIDS Society;2024-02

2. Temporal dynamics and drivers of durable HIV viral load suppression and persistent high- and low-level viremia during Universal Test and Treat scale-up in Uganda: a population-based study;2023-06-16

3. Associations between HIV viremia during antiretroviral therapy and cardiovascular disease;AIDS;2022-06-22

4. START (Supporting Treatment Adherence Readiness through Training) Improves Both HIV Antiretroviral Adherence and Viral Reduction, and is Cost Effective: Results of a Multi-site Randomized Controlled Trial;AIDS and Behavior;2021-04-02

5. Survivability and Growth Model Approach to CD4 Counts of PLHIVs;HIV Transmission;2019-11-30